期刊
INTERNATIONAL JOURNAL OF ONCOLOGY
卷 60, 期 2, 页码 -出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/ijo.2022.5302
关键词
tumour; immunotherapy; monoclonal antibody; phage display technology; A single B cell monoclonal antibody generation technology
类别
资金
- National Natural Science Foundation of China [82060638]
- `Double 10-Thousand Plan' of Jiangxi Province (Innovation and Technology Professionals as the High-End Talent)
Monoclonal antibody technology plays a vital role in biomedical and immunotherapy, and various techniques have been developed to generate different types of monoclonal antibodies, which have been widely used in disease research and treatment.
Monoclonal antibody technology plays a vital role in biomedical and immunotherapy, which greatly promotes the study of the structure and function of genes and proteins. To date, monoclonal antibodies have gone through four stages: murine monoclonal antibody, chimeric monoclonal antibody, humanised monoclonal antibody and fully human monoclonal antibody; thousands of monoclonal antibodies have been used in the fields of biology and medicine, playing a special role in the pathogenesis, diagnosis and treatment of disease. In this review, we compare the advantages and disadvantages of hybridoma technology, phage display technology, ribosome display technology, transgenic mouse technology, single B cell monoclonal antibody generation technologies, and forecast the promising applications of these technologies in clinical medicine, disease diagnosis and tumour treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据